Distinctive role of starD 13 in serous ovarian carcinoma cell proliferation, metastasis, and invadopodia assembly. (c2019)

Ovarian carcinoma is the second most leading cause of deaths among female reproductive system malignant tumors. Serous epithelial carcinomas have a poor treatment rates for it is most likely to be advanced when diagnosed due to its poor indications and symptoms. Ovarian serous carcinomas are mainly...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلف الرئيسي: Abdullatef, Sandra (author)
التنسيق: masterThesis
منشور في: 2019
الموضوعات:
الوصول للمادة أونلاين:http://hdl.handle.net/10725/11576
https://doi.org/10.26756/th.2019.142
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
_version_ 1864513489229316096
author Abdullatef, Sandra
author_facet Abdullatef, Sandra
author_role author
dc.creator.none.fl_str_mv Abdullatef, Sandra
dc.date.none.fl_str_mv 2019-11-25T09:46:17Z
2019-11-25T09:46:17Z
2019
2019-11-25
2019-05-06
dc.identifier.none.fl_str_mv http://hdl.handle.net/10725/11576
https://doi.org/10.26756/th.2019.142
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php
dc.language.none.fl_str_mv en
dc.publisher.none.fl_str_mv Lebanese American University
dc.rights.*.fl_str_mv info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Lebanese American University -- Dissertations
Dissertations, Academic
Ovaries -- Cancer -- Treatment
GTPase-activating protein
dc.title.none.fl_str_mv Distinctive role of starD 13 in serous ovarian carcinoma cell proliferation, metastasis, and invadopodia assembly. (c2019)
dc.type.none.fl_str_mv Thesis
info:eu-repo/semantics/publishedVersion
info:eu-repo/semantics/masterThesis
description Ovarian carcinoma is the second most leading cause of deaths among female reproductive system malignant tumors. Serous epithelial carcinomas have a poor treatment rates for it is most likely to be advanced when diagnosed due to its poor indications and symptoms. Ovarian serous carcinomas are mainly divided into different stages according to the invasiveness and metastatic ability of the tumor. Many mutations are acquired which lead to the development of this malignancy. This occur in entities that greatly affect the cell cycle, cell signaling pathways and cell motility, which all involve the action of Rho GTPases. The protein of interest in the present study was DLC2, also known as StarD13 or START-GAP2, a GTPaseactivating protein (GAP) for Rhoa and Cdc42. Literature data indicate that this protein is considered a tumor-suppressor in hepatocellular carcinoma. Previous research in our laboratory confirmed StarD13 as a tumor suppressor in astrocytoma, in breast cancer, and in colon cancer. In this study, we aim to investigate the role of StarD13 in cell migration, invasion, and proliferation. The results show that StarD13 is a tumor suppressor in ovarian serous carcinoma, it inhibits the function of cdc42 leading to the decrease in invadopodia assembly hence hindering invasion. StarD13 is needed for cell motility via its indirect effect on RhoA activation cycle. Moreover, StarD13 knockdown increased cell adhesiveness via the crosstalk between Cdc42 and Rac1 pathway. Therefore the cells were not being able to detach and move. Establishing the conclusion that StarD13 is in fact a tumor suppressor but it is needed for cell motility in ovarian cancer.
eu_rights_str_mv openAccess
format masterThesis
id LAURepo_e038006a4053c7b34ca786909a00f4e3
language_invalid_str_mv en
network_acronym_str LAURepo
network_name_str Lebanese American University repository
oai_identifier_str oai:laur.lau.edu.lb:10725/11576
publishDate 2019
publisher.none.fl_str_mv Lebanese American University
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
spelling Distinctive role of starD 13 in serous ovarian carcinoma cell proliferation, metastasis, and invadopodia assembly. (c2019)Abdullatef, SandraLebanese American University -- DissertationsDissertations, AcademicOvaries -- Cancer -- TreatmentGTPase-activating proteinOvarian carcinoma is the second most leading cause of deaths among female reproductive system malignant tumors. Serous epithelial carcinomas have a poor treatment rates for it is most likely to be advanced when diagnosed due to its poor indications and symptoms. Ovarian serous carcinomas are mainly divided into different stages according to the invasiveness and metastatic ability of the tumor. Many mutations are acquired which lead to the development of this malignancy. This occur in entities that greatly affect the cell cycle, cell signaling pathways and cell motility, which all involve the action of Rho GTPases. The protein of interest in the present study was DLC2, also known as StarD13 or START-GAP2, a GTPaseactivating protein (GAP) for Rhoa and Cdc42. Literature data indicate that this protein is considered a tumor-suppressor in hepatocellular carcinoma. Previous research in our laboratory confirmed StarD13 as a tumor suppressor in astrocytoma, in breast cancer, and in colon cancer. In this study, we aim to investigate the role of StarD13 in cell migration, invasion, and proliferation. The results show that StarD13 is a tumor suppressor in ovarian serous carcinoma, it inhibits the function of cdc42 leading to the decrease in invadopodia assembly hence hindering invasion. StarD13 is needed for cell motility via its indirect effect on RhoA activation cycle. Moreover, StarD13 knockdown increased cell adhesiveness via the crosstalk between Cdc42 and Rac1 pathway. Therefore the cells were not being able to detach and move. Establishing the conclusion that StarD13 is in fact a tumor suppressor but it is needed for cell motility in ovarian cancer.24M1 hard copy: xv, 64 leaves; col. ill. charts; 30 cm. available at RNL.Bibliography: (leaves 53-64).Lebanese American University2019-11-25T09:46:17Z2019-11-25T09:46:17Z20192019-11-252019-05-06Thesisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesishttp://hdl.handle.net/10725/11576https://doi.org/10.26756/th.2019.142http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.phpeninfo:eu-repo/semantics/openAccessoai:laur.lau.edu.lb:10725/115762021-03-19T10:47:38Z
spellingShingle Distinctive role of starD 13 in serous ovarian carcinoma cell proliferation, metastasis, and invadopodia assembly. (c2019)
Abdullatef, Sandra
Lebanese American University -- Dissertations
Dissertations, Academic
Ovaries -- Cancer -- Treatment
GTPase-activating protein
status_str publishedVersion
title Distinctive role of starD 13 in serous ovarian carcinoma cell proliferation, metastasis, and invadopodia assembly. (c2019)
title_full Distinctive role of starD 13 in serous ovarian carcinoma cell proliferation, metastasis, and invadopodia assembly. (c2019)
title_fullStr Distinctive role of starD 13 in serous ovarian carcinoma cell proliferation, metastasis, and invadopodia assembly. (c2019)
title_full_unstemmed Distinctive role of starD 13 in serous ovarian carcinoma cell proliferation, metastasis, and invadopodia assembly. (c2019)
title_short Distinctive role of starD 13 in serous ovarian carcinoma cell proliferation, metastasis, and invadopodia assembly. (c2019)
title_sort Distinctive role of starD 13 in serous ovarian carcinoma cell proliferation, metastasis, and invadopodia assembly. (c2019)
topic Lebanese American University -- Dissertations
Dissertations, Academic
Ovaries -- Cancer -- Treatment
GTPase-activating protein
url http://hdl.handle.net/10725/11576
https://doi.org/10.26756/th.2019.142
http://libraries.lau.edu.lb/research/laur/terms-of-use/thesis.php